These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 20403460)
1. Myricetin inhibits IL-1beta-induced inflammatory mediators in SW982 human synovial sarcoma cells. Lee YS; Choi EM Int Immunopharmacol; 2010 Jul; 10(7):812-4. PubMed ID: 20403460 [TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts. Bradley K; Scatizzi JC; Fiore S; Shamiyeh E; Koch AE; Firestein GS; Gorges LL; Kuntsman K; Pope RM; Moore TL; Han J; Perlman H Arthritis Rheum; 2004 Jan; 50(1):78-87. PubMed ID: 14730602 [TBL] [Abstract][Full Text] [Related]
3. Effects of hesperetin on the production of inflammatory mediators in IL-1beta treated human synovial cells. Choi EM; Lee YS Cell Immunol; 2010; 264(1):1-3. PubMed ID: 20538267 [TBL] [Abstract][Full Text] [Related]
4. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38. Hiramitsu T; Yasuda T; Ito H; Shimizu M; Julovi SM; Kakinuma T; Akiyoshi M; Yoshida M; Nakamura T Rheumatology (Oxford); 2006 Jul; 45(7):824-32. PubMed ID: 16449361 [TBL] [Abstract][Full Text] [Related]
5. Luteolin suppresses IL-1beta-induced cytokines and MMPs production via p38 MAPK, JNK, NF-kappaB and AP-1 activation in human synovial sarcoma cell line, SW982. Choi EM; Lee YS Food Chem Toxicol; 2010 Oct; 48(10):2607-11. PubMed ID: 20600535 [TBL] [Abstract][Full Text] [Related]
7. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243 [TBL] [Abstract][Full Text] [Related]
8. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis. Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214 [TBL] [Abstract][Full Text] [Related]
9. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes. Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: involvement of ERK, JNK, AP-1, and NF-kappaB. Yang CM; Luo SF; Hsieh HL; Chi PL; Lin CC; Wu CC; Hsiao LD J Cell Physiol; 2010 Aug; 224(2):516-26. PubMed ID: 20432452 [TBL] [Abstract][Full Text] [Related]
11. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Schett G; Tohidast-Akrad M; Smolen JS; Schmid BJ; Steiner CW; Bitzan P; Zenz P; Redlich K; Xu Q; Steiner G Arthritis Rheum; 2000 Nov; 43(11):2501-12. PubMed ID: 11083274 [TBL] [Abstract][Full Text] [Related]
12. Kaempferol inhibits IL-1β-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs. Yoon HY; Lee EG; Lee H; Cho IJ; Choi YJ; Sung MS; Yoo HG; Yoo WH Int J Mol Med; 2013 Oct; 32(4):971-7. PubMed ID: 23934131 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38. Julovi SM; Ito H; Nishitani K; Jackson CJ; Nakamura T J Orthop Res; 2011 Feb; 29(2):258-64. PubMed ID: 20706991 [TBL] [Abstract][Full Text] [Related]
14. FK506 suppresses the stimulation of matrix metalloproteinase 13 synthesis by interleukin-1beta in rheumatoid synovial fibroblasts. Migita K; Miyashita T; Maeda Y; Aoyagi T; Kawabe Y; Nakamura M; Yatsuhashi H; Ishibashi H; Eguchi K Immunol Lett; 2005 May; 98(2):194-9. PubMed ID: 15860218 [TBL] [Abstract][Full Text] [Related]
15. SeMet inhibits IL-1β-induced rheumatoid fibroblast-like synoviocytes proliferation and the production of inflammatory mediators. Ying X; Chen X; Cheng S; Zhao Z; Guo X; Chen H; Hong J; Peng L; Xu H Biol Trace Elem Res; 2013 Jun; 153(1-3):437-45. PubMed ID: 23681674 [TBL] [Abstract][Full Text] [Related]
17. Polyphenolic extract from extra virgin olive oil inhibits the inflammatory response in IL-1β-activated synovial fibroblasts. Rosillo MÁ; Alarcón-de-la-Lastra C; Castejón ML; Montoya T; Cejudo-Guillén M; Sánchez-Hidalgo M Br J Nutr; 2019 Jan; 121(1):55-62. PubMed ID: 30360768 [TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Ahmed S; Pakozdi A; Koch AE Arthritis Rheum; 2006 Aug; 54(8):2393-401. PubMed ID: 16869002 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells. Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279 [TBL] [Abstract][Full Text] [Related]
20. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs. Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]